OpenAlex
PricingAboutJobs
Log inGet started
Work

Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease

HTML

Year: 2009
Type: review
Source: Expert Opinion on Pharmacotherapy
DOI: 10.1517/14656560903044982
Authors: David B Henley, Patrick C May, Robert A Dean, Eric R Siemers
Institution: Eli Lilly (United States)
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: semagacestat, gamma-secretase inhibitors, Alzheimer's disease, amyloid-beta, amyloid plaques, Notch signaling, cerebrospinal fluid amyloid-beta, plasma amyloid-beta, drug tolerability
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2065706231
FWCI: 1.524
Cites: 37
Cited by: 183
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security